GAITHERSBURG, Md. — Governor Larry Hogan on Thursday visited a Gaithersburg laboratory, that's in the process of developing a possible COVID-19 vaccine.
Novavax Inc., was awarded $1.6 billion through the Federal Government's Operation Warp Speed to produce large-scale manufacturing, and delivery of 100 million vaccine doses as early as late 2020.
The company is just one of several in Montgomery County and Baltimore, helping to find a vaccine.
Emergent BioSolutions, also headquartered in Gaithersburg, has been tapped to support Novavax with development and manufacturing.
They will also assist AstraZeneca and Johnson & Johnson with their clinical trials.
Meanwhile, Altimmune out of Gaithersburg, was awarded a federal contract to work with Rockville-based Vigene Biosciences on the development of a single-dose intranasal COVID-19 vaccine.
Then there is Longhorn Vaccines and Diagnostics out of Bethesda, who will transport clinical samples to testing labs.
To date, Maryland’s life sciences companies have secured more than $3 billion for the development of a vaccine for SARS-CoV-2, the virus that causes COVID-19.
The University System of Maryland and Johns Hopkins University have also dedicated millions of dollars toward research, testing, and clinical trials. The University of Maryland School of Medicine recently began phase 3 trials of a COVID-19 vaccine.
